Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name LVGN3616
Trade Name
Synonyms LVGN-3616|LVGN 3616
Drug Descriptions

LVGN3616 is a humanized monoclonal antibody that targets PD-1 (PDCD1), potentially resulting in restoration of T-cell mediated immune response (NCI Thesaurus).

DrugClasses Immune Checkpoint Inhibitor 148 PD-L1/PD-1 antibody 93
CAS Registry Number NA
NCIT ID C178280


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bevacizumab + Cyclophosphamide + LVGN3616 + LVGN6051 Bevacizumab Cyclophosphamide LVGN3616 LVGN6051 0 1
Bevacizumab + Cyclophosphamide + LVGN3616 + LVGN6051 + LVGN7409 Bevacizumab Cyclophosphamide LVGN3616 LVGN6051 LVGN7409 0 1
LVGN3616 LVGN3616 0 0
LVGN3616 + LVGN6051 + LVGN7409 + Nab-paclitaxel LVGN3616 LVGN6051 LVGN7409 Nab-paclitaxel 0 1
LVGN3616 + LVGN6501 + Nab-paclitaxel LVGN3616 LVGN6501 Nab-paclitaxel 0 1

Additional content available in CKB BOOST